Actively Recruiting
OROPHARYNGEAL MYOFUNCTIONAL THERAPY IN OBSTRUCTIVE SLEEP APNEA
Led by Instituto de Investigación Marqués de Valdecilla · Updated on 2024-11-14
30
Participants Needed
1
Research Sites
82 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Obstructive Sleep Apnea (OSA) is a prevalent nocturnal breathing disorder among the general population. Oropharyngeal myofunctional therapy (OMT) is an alternative conservative treatment used to improve OSA, associated health problems, and to improve the efficacy and tolerability of CPAP. The objective is to determine the effect of OMT in the general population with mild-moderate OSA. The overall study design will be a randomized controlled clinical trial with parallel groups. Both the control group and the intervention group will receive the same indications on the hygienic-dietary measures to be followed. The intervention group will also follow an exercise program based on OMT for 20 weeks. The effect on the apnea-hypopnea index and other variables will be determined by means of respiratory polygraphy before and after the intervention.
CONDITIONS
Official Title
OROPHARYNGEAL MYOFUNCTIONAL THERAPY IN OBSTRUCTIVE SLEEP APNEA
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent
- Diagnosis of mild to moderate Obstructive Sleep Apnea without need for CPAP or other advanced treatments
- Patients who refused or are not candidates for CPAP or other treatments
- Age greater than 18 years and less than 70 years
You will not qualify if you...
- Craniofacial malformations, severe developmental delay, or intellectual disability
- Diagnosis of neurodegenerative disease
- Limited tongue mobility, ankyloglossia, or Temporo-Mandibular Joint pathology
- Regular use of hypnotic medications
- Bulbar pathologies
- Central sleep apnea with more than 50% of total sleep time
- Obesity grade II or higher
- Severe cardiovascular, neuromuscular, or pulmonary disease or chronic oxygen use
- Hypoventilation-obesity syndrome
- Refusal to participate despite meeting inclusion criteria and no exclusions
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital universitario Marques de Valdecilla
Santander, Spain
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here